Literature DB >> 16810511

Low protein Z levels in children with nephrotic syndrome.

Ozan Ozkaya1, Kenan Bek, Tunc Fişgin, Yuksel Aliyazicioğlu, Sevinc Sultansuyu, Yonca Açikgöz, Davut Albayrak, Kemal Baysal.   

Abstract

Acquired deficiency of anticoagulant proteins, due to loss in the urine, has been proposed as one of the major thrombogenic alterations in nephrotic syndrome (NS). Protein Z (PZ) is a single-chain vitamin K-dependent glycoprotein. Low PZ levels are reported to be a risk factor for thrombosis. The aim of this study was to investigate protein Z and other natural anticoagulant levels in children with NS. Thirty children aged between 1.5 and 12 years with NS (Groups I and II) and 19 age-and-sex-matched healthy controls (Group III) were enrolled into the study. Patients were divided into two groups: Group I (proteinuria >40 mg/m2/hr) and Group II (patients in remission). Plasma PZ levels in Group I were significantly lower than Group II (p=0.009) and group III (p=0.018). Plasma levels of AT III for Group I were significantly lower than for Groups II and III (p=0.009, p=0.005, respectively). Protein C levels in Group I were higher than in Group II and Group III (p=0.002, p=0.000, respectively). Protein Z levels positively correlated with serum total protein and albumin levels (p=0.003, p=0.003, respectively) and negatively with the degree of proteinuria (p=0.000). Protein Z levels were positively correlated with AT III (r=0.037, p=0.04). Along with the other coagulation abnormalities, decreased protein Z may contribute to increased risk of thromboembolic complications in children with NS. The negative correlation between proteinuria and PZ level suggests the possibility of renal PZ loss. Further studies are needed to investigate the mechanism and role of decreased PZ in NS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810511     DOI: 10.1007/s00467-006-0167-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Barbara Tomaszewska; Anna Biernacka
Journal:  Pediatr Nephrol       Date:  2004-10-13       Impact factor: 3.714

Review 2.  Protein Z.

Authors:  B Kemkes-Matthes; K J Matthes
Journal:  Semin Thromb Hemost       Date:  2001-10       Impact factor: 4.180

3.  Hemostatic problems and thromboembolic complications in nephrotic children.

Authors:  A Citak; S Emre; A Sâirin; I Bilge; A Nayir
Journal:  Pediatr Nephrol       Date:  2000-02       Impact factor: 3.714

Review 4.  Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

Authors:  F Llach
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

5.  Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis.

Authors:  Ali Al-Shanqeeti; Astrid van Hylckama Vlieg; Erik Berntorp; Frits R Rosendaal; George J Broze
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

6.  Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity.

Authors:  Neşe Ozkayin; Sevgi Mir; Kaan Kavakli
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

8.  Coagulopathy of childhood nephrotic syndrome--a reappraisal of the role of natural anticoagulants and fibrinolysis.

Authors:  M M al-Mugeiren; A M Gader; S A al-Rasheed; H M Bahakim; A K al-Momen; A al-Salloum
Journal:  Haemostasis       Date:  1996 Nov-Dec

9.  Frequency of protein Z deficiency in patients with ischaemic stroke.

Authors:  M Vasse; E Guegan-Massardier; J Y Borg; F Woimant; C Soria
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

10.  Surface markers of platelet function in idiopathic nephrotic syndrome in children.

Authors:  Marcin Tkaczyk; Zbigniew Baj
Journal:  Pediatr Nephrol       Date:  2002-05-17       Impact factor: 3.714

View more
  3 in total

1.  Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome.

Authors:  Farida Ahmed Farid; Ahmed Abdullah Mohammed; Hanaa Mohammed Afifi; Rania Saleh Beltagi
Journal:  SAJCH       Date:  2011-12

Review 2.  Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.

Authors:  Bryce A Kerlin; Rose Ayoob; William E Smoyer
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

3.  Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study.

Authors:  Bryce A Kerlin; Neal B Blatt; Beng Fuh; Shuang Zhao; Amy Lehman; Carol Blanchong; John D Mahan; William E Smoyer
Journal:  J Pediatr       Date:  2009-04-24       Impact factor: 4.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.